Equity awards to GE HealthCare (GEHC) Imaging CEO Roland Rott detailed

Rhea-AI Filing Summary

GE HealthCare Technologies Inc. reported that Roland Rott, CEO of Imaging, received new equity awards. He was granted employee stock options for 22,548 shares at an exercise price of $0.00 per share and 8,576 shares of common stock as a stock-based award.

The restricted stock units for 8,576 shares will vest in stages, with 33% on September 2, 2027, 33% on September 2, 2028, and 34% on September 2, 2029. The 22,548 stock options follow the same 33%/33%/34% exercisability schedule on those dates.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Rott Roland

Role CEO, Imaging

Type	Security	Shares	Price	Value
Grant/Award	Employee Stock Option (right to buy)	22,548	$0.00	--
Grant/Award	Common Stock, par value $0.01 per share	8,576	$0.00	--

Holdings After Transaction: Employee Stock Option (right to buy) — 22,548 shares (Direct); Common Stock, par value $0.01 per share — 41,082 shares (Direct)

Footnotes (1)

1. Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare Technologies Inc. ("GE HealthCare") common stock. Award of restricted stock units with respect to GE HealthCare common stock, of which 33% will vest on September 2, 2027, 33% will vest on September 2, 2028, and 34% will vest on September 2, 2029. Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 2, 2027, 33% will become exercisable on September 2, 2028, and 34% will become exercisable on September 2, 2029.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Rott Roland

(Last) (First) (Middle)

500 W. MONROE STREET

(Street)

CHICAGO IL 60661

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
GE HealthCare Technologies Inc. [ GEHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CEO, Imaging

3. Date of Earliest Transaction (Month/Day/Year)
03/02/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, par value $0.01 per share	03/02/2026		A		8,576(1)(2)	A	$0	41,082	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (right to buy)	$80.16	03/02/2026		A		22,548		(3)	03/02/2036	Common Stock, par value $0.01 per share	22,548	$0(3)	22,548	D

Explanation of Responses:

1. Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare Technologies Inc. ("GE HealthCare") common stock.

2. Award of restricted stock units with respect to GE HealthCare common stock, of which 33% will vest on September 2, 2027, 33% will vest on September 2, 2028, and 34% will vest on September 2, 2029.

3. Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 2, 2027, 33% will become exercisable on September 2, 2028, and 34% will become exercisable on September 2, 2029.

Remarks:

	/s/ Frank R. Jimenez, General Counsel and Corporate Secretary, as attorney-in-fact	03/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What equity awards did GEHC executive Roland Rott receive in this Form 4?

Roland Rott received a grant of 22,548 employee stock options and 8,576 shares of GE HealthCare common stock. These represent stock-based compensation awards rather than open-market purchases, with vesting and exercisability spread over several future dates.

How many GEHC employee stock options were granted to Roland Rott?

Roland Rott was granted 22,548 employee stock options at an exercise price of $0.00 per share. These options become exercisable in three tranches: 33% in 2027, 33% in 2028, and the remaining 34% in 2029, subject to continued service conditions.

What common stock award did Roland Rott report for GEHC?

He reported an award of 8,576 shares of GE HealthCare common stock, delivered via restricted stock units. Each unit represents one share at settlement, with vesting scheduled over three years in 33%, 33%, and 34% portions through 2029, aligning incentives with longer-term performance.

When do Roland Rott’s GE HealthCare restricted stock units vest?

The restricted stock units vest over three dates: 33% on September 2, 2027, another 33% on September 2, 2028, and the remaining 34% on September 2, 2029. This multi-year vesting encourages sustained tenure and focus on long-term company performance.

When do Roland Rott’s GEHC employee stock options become exercisable?

The employee stock options become exercisable in three stages: 33% on September 2, 2027, 33% on September 2, 2028, and 34% on September 2, 2029. This staggered schedule ties potential option value to multi-year company outcomes.

Did Roland Rott buy or sell GE HealthCare shares in the market?

The transactions reported are grants and awards classified under code “A” for acquisitions, not open-market buys or sells. They reflect stock-based compensation in the form of restricted stock units and employee stock options with future vesting and exercisability conditions.